UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, ...

While China has long been touted as the next great economic superpower, its recent trajectory reveals a far different story.

Abbott Laboratories' second-largest division, diagnostics, continues to be a hindrance, while the FY group operating margin ...

The Federal Trade Commission set aside orders barring Hess CEO John Hess from joining Chevron's board and former Pioneer ...

Property REITs remain attractive despite high rates, with low leverage, fixed-rate debt, and strong income growth. Read more ...

The direct lending market has experienced dramatic growth and become a vital and growing part of institutional investors’ ...

ProShares Ultra S&P500 ETF offers leveraged exposure, amplifying both gains and losses. Read why we do not recommend SSO as a ...

Select Medical remains a soft 'buy' amid organic growth and solid performance, despite risks like Medicaid changes and recent ...

Trump is unlikely to further delay tariffs; significantly higher tariffs will be imposed on August 1st. Read why investors ...

Canadian Natural is a high cash flow, low-cost producer with strong returns and further opportunities to expand its ...

Learn why the US Dollar's decline highlights the importance of international diversification for dividend investors.